Science

Mark Lythgoe: Do We Need to Rationalise CT Scans in Medicine?

Mark Lythgoe/X

May 6, 2025, 10:59

Mark Lythgoe: Do We Need to Rationalise CT Scans in Medicine?

Mark Lythgoe, Clinical Research Fellow in Oncology therapy/drug development at Imperial College London, shared a post on X about a paper by Rebecca Smith-Bindman et al. published in JAMA Internal Medicine:

“Do we need to rationalise CT Scans in medicine? Study in JAMA Internal Medicine suggests current CT usage could result in 1 in 20 of ALL cancers in the near future…”

Title: Projected Lifetime Cancer Risks From Current Computed Tomography Imaging

Authors: Rebecca Smith-Bindman, Philip Chu, Hana Azman Firdaus, Carly Stewart, Matthew Malekhedayat, Susan Alber, Wesley Bolch, Malini Mahendra, Amy Berrington de González, Diana Miglioretti.

Read the Full Article on JAMA Internal Medicine.

More posts featuring Mark Lythgoe.

Amy Berrington de González cancer cancer risks Carly Stewart computed tomography CT Diana Miglioretti Hana Azman Firdaus JAMA Internal Medicine Malini Mahendra Mark Lythgoe Matthew Malekhedayat OncoDaily Oncology Philip Chu Rebecca Smith-Bindman Susan Alber Wesley Bolch

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action